ATLASOlema Pharmaceuticals (OLMA) earnings date: Nov 9, 2026
Olema Pharmaceuticals (OLMA) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, after the close. Analysts expect EPS of -$0.60.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on OLMA
| Last price | $7.01 (+0.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Olema Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Olema Pharmaceuticals reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Olema Pharmaceuticals. You can switch it off at any time.
Alert me before OLMA reportsFree to start. Creating an account takes under a minute.
Notify me when Olema Pharmaceuticals reports
Track OLMA free Add Olema Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
OLMA earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.60 |
| Last report | Aug 10, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -1.2% |
| Average move around a report | ±5.4% (last 5) |
| Sector | Healthcare · Biotechnology |
Olema Pharmaceuticals earnings history: last 5 reports
Olema Pharmaceuticals last reported on Aug 10, 2026: EPS of -$0.61 against an estimate of -$0.56 (-8.9% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.56 | -$0.61 | -8.9% | Miss | -13.4% |
| May 12, 2026 | -$0.54 | -$0.52 | +3.7% | Beat | -8.6% |
| Apr 2, 2026 | -$0.62 | -$0.71 | -14.5% | Miss | +0.3% |
| Mar 16, 2026 | -$0.53 | -$0.50 | +5.7% | Beat | +2.4% |
| Jan 27, 2026 | $2.20 | $2.38 | +8.2% | Beat | -2.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for OLMA
See the fair value, the probability range and the earnings history of Olema Pharmaceuticals on its ATLAS page.
Olema Pharmaceuticals (OLMA) stock analysisPlans from €3.99 a month.
Olema Pharmaceuticals earnings: frequently asked questions
When does Olema Pharmaceuticals (OLMA) report earnings?
Olema Pharmaceuticals is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for OLMA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.60 per share (USD). Estimates can change before the report.
How often does OLMA beat earnings estimates?
Of its last 5 reports with a recorded result, Olema Pharmaceuticals beat the EPS estimate 3 times; the average surprise was -1.2%. Past results do not predict the next one.
How much does OLMA move around earnings?
Over its last 5 reports the stock moved an average of 5.4% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Olema Pharmaceuticals beat earnings estimates last quarter?
Olema Pharmaceuticals last reported on Aug 10, 2026: EPS of -$0.61 against an estimate of -$0.56 (-8.9% surprise), a miss.
How much does OLMA usually move in a day?
On a normal trading day the ATLAS model puts OLMA’s one-day range at about ±4.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer